New research from Heinz Ludwig, MD et al explores the global interrelations between Multiple Myeloma (MM) mortality and countries’ economic resources, patient empowerment, and health access and quality. The study is intended to inform about the associations between these factors, and to improve diagnosis, management, and outcome of patients globally.

Studies centering on vaccinations for myeloma patients have been limited in the past due to their low participation rate in trials coupled with negligent measures of patient outcomes. Learn about compilation of vaccination data.